{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T05:54:06Z","timestamp":1690782846077},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Possible ectopic parathyroid hormone (PTH) production in adipose tissues surrounding hyperplastic parathyroid glands was examined in patients with secondary hyperparathyroidism (SHPT). <jats:italic>In vitro<\/jats:italic> culture of adipose tissues from 31 patients excised during parathyroidectomy showed PTH secretion in 23 (74.2%) patients. <jats:italic>In vitro<\/jats:italic> PTH secretion was detected in adipose tissues adhered to the parathyroid glands from 22 (71.0%) patients, in not-adhered adipose from 11 (35.5%) and in the thymus from four (28.6%) patients. Immunohistochemistry revealed colonies of PTH- and GCM2-positive cells intricately intertwined with adipocytes in excised adipose tissues prior to culture. When pieces of parathyroid parenchyma from SHPT patients were transplanted into the thyroid of immunodeficient nude rats with induced SHPT, the transplants secreted human PTH for one to three-and-half months after transplantation and expressed adipocyte markers, PPAR\u03b32 and perilipin A, that the transplants did not express prior to transplantation. These findings indicate the importance of thoroughly removing adipose tissues surrounding the parathyroid glands when performing parathyroidectomy. We speculate that these ectopic PTH-producing cells are parathyroid parenchymal cells pushed out from the glands along with adipocyte progenitors during nodular growth of hyperplastic parenchymal cells and that these cells proliferate in SHPT, forming colonies PTH-producing cells intricately intertwined with adipocytes.<\/jats:p>","DOI":"10.1038\/s41598-020-60045-y","type":"journal-article","created":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T11:07:31Z","timestamp":1582542451000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Parathyroid hormone-producing cells exist in adipose tissues surrounding the parathyroid glands in hemodialysis patients with secondary hyperparathyroidism"],"prefix":"10.1038","volume":"10","author":[{"given":"Takatoshi","family":"Kakuta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaichiro","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genta","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoko","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayo","family":"Miyakogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raima","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Fukagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,24]]},"reference":[{"key":"60045_CR1","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s10157-011-0502-5","volume":"15","author":"H Komaba","year":"2011","unstructured":"Komaba, H., Kakuta, T. & Fukagawa, M. Diseases of the parathyroid gland in chronic kidney disease. Clin. Exp. Nephrol. 15, 797\u2013809 (2011).","journal-title":"Clin. Exp. Nephrol."},{"key":"60045_CR2","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1681\/ASN.V1341017","volume":"13","author":"WG Goodman","year":"2002","unstructured":"Goodman, W. G. et al. The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism. J. Am. Soc. Nephrol. 13, 1017\u20131024 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"60045_CR3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/ndt\/gfm534","volume":"23","author":"M Fukagawa","year":"2008","unstructured":"Fukagawa, M. et al. Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients. Nephrol. Dial. Transplant. 23, 328\u2013335 (2008).","journal-title":"Nephrol. Dial. Transplant."},{"key":"60045_CR4","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1001\/jama.2016.19456","volume":"3117","author":"GA Block","year":"2017","unstructured":"Block, G. A. et al. Effect of etelcalcetide vs placebo on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism. Two randomized clinical trials. JAMA. 3117, 146\u2013155 (2017).","journal-title":"JAMA."},{"key":"60045_CR5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1001\/jama.2016.19468","volume":"317","author":"GA Block","year":"2017","unstructured":"Block, G. A. et al. Effect of etelcalcetide vs cinacalcet on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism. A randomized clinical trial. JAMA. 317, 156\u2013164 (2017).","journal-title":"JAMA."},{"key":"60045_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/1744-9987.12352","volume":"20","author":"Y Tominaga","year":"2016","unstructured":"Tominaga, Y. et al. Evaluation of parathyroidectomy for secondary and tertiary hyperparathyroidism by the Parathyroid Surgeons\u2019 Society of Japan. Ther. Apher. Dial. 20, 6\u201311 (2016).","journal-title":"Ther. Apher. Dial."},{"key":"60045_CR7","doi-asserted-by":"publisher","first-page":"755","DOI":"10.5301\/jn.5000056","volume":"25","author":"N Iwamoto","year":"2012","unstructured":"Iwamoto, N. et al. Total parathyroidectomy improves survival of hemodialysis patients with secondary hyperparathyroidism. J. Nephrol. 25, 755\u2013763 (2012).","journal-title":"J. Nephrol."},{"key":"60045_CR8","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1744-9987.2008.00648.x","volume":"12","author":"Guideline Working Group","year":"2008","unstructured":"Guideline Working Group. Japanese Society for Dialysis Therapy: Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients. Ther. Apher. Dial. 12, 514\u2013525 (2008).","journal-title":"Ther. Apher. Dial."},{"key":"60045_CR9","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/ki.1997.448","volume":"52","author":"E Lewin","year":"1997","unstructured":"Lewin, E., Wang, W. & Olgaard, K. Reversibility of experimental secondary hyperparathyroidism. Kidney Int. 52, 1232\u20131241 (1997).","journal-title":"Kidney Int."},{"key":"60045_CR10","doi-asserted-by":"publisher","first-page":"11839","DOI":"10.1073\/pnas.0404474101","volume":"101","author":"S Kelly","year":"2004","unstructured":"Kelly, S. et al. Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc. Natl. Acad. Sci. 101, 11839\u201311844 (2004).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"60045_CR11","doi-asserted-by":"crossref","first-page":"11341","DOI":"10.1016\/S0021-9258(18)99168-4","volume":"266","author":"AS Greenberg","year":"1991","unstructured":"Greenberg, A. S. et al. Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of lipid storage droplets. J. Biol. Chem. 266, 11341\u201311346 (1991).","journal-title":"J. Biol. Chem."},{"key":"60045_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ydbio.2007.02.014","volume":"305","author":"Z Liu","year":"2007","unstructured":"Liu, Z., Yu, S. & Manley, N. R. Gcm2 is required for the differentiation and survival of parathyroid precursor cells in the parathyroid\/thymus primordia. Dev. Biol. 305, 333\u2013346 (2007).","journal-title":"Dev. Biol."},{"key":"60045_CR13","doi-asserted-by":"publisher","first-page":"e0210662","DOI":"10.1371\/journal.pone.0210662","volume":"14","author":"T Yamada","year":"2019","unstructured":"Yamada, T. et al. Gcm2 regulates the maintenance of parathyroid cells in adult mice. PLoS ONE 14, e0210662 (2019).","journal-title":"PLoS ONE"},{"key":"60045_CR14","unstructured":"Young, B., Heath, J. W., Stevens, A. & Burkitt, H. G. Wheater\u2019s Functional Histology: A text and colour atlas (5th ed.). 337 (Edinburgh: Churchill Livingstone\/Elsevier. 2006)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60045-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60045-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60045-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T07:49:13Z","timestamp":1670312953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60045-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,24]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["60045"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-60045-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,24]]},"assertion":[{"value":"20 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.K. has received honoraria from the Kyowa Kirin Co.ltd and Chugai Pharmaceutical. M.F. has acted as a consultant for the Kyowa Kirin Co.ltd, Bayer Japan, and Novartis; has received honoraria from the Kyowa Kirin Co.ltd, Chugai Pharmaceutical, Bayer Yakuhin, Novartis, Genzyme, and Abbot Japan; and has received grants\/research support from the Kyowa Kirin Co.ltd, Chugai Pharmaceutical, and Bayer Yakuhin. The other authors declare that they have no relevant financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3290"}}